Vanda Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. 

CEO
Mihael Hristos Polymeropoulos
CEOMihael Hristos Polymeropoulos
Employees
368
Employees368
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
2002
Founded2002
Employees
368
Employees368

VNDA Key Statistics

Market cap
487.25M
Market cap487.25M
Price-Earnings ratio
-6.16
Price-Earnings ratio-6.16
Dividend yield
Dividend yield
Average volume
3.87M
Average volume3.87M
High today
$8.91
High today$8.91
Low today
$7.93
Low today$7.93
Open price
$8.73
Open price$8.73
Volume
4.94M
Volume4.94M
52 Week high
$9.60
52 Week high$9.60
52 Week low
$3.81
52 Week low$3.81

Stock Snapshot

With a market cap of 487.25M, Vanda Pharmaceuticals(VNDA) trades at $8.20. The stock has a price-to-earnings ratio of -6.16.

During the trading session on 2026-01-02, Vanda Pharmaceuticals(VNDA) shares reached a daily high of $8.91 and a low of $7.93. At a current price of $8.20, the stock is +3.4% higher than the low and still -7.9% under the high.

Trading activity shows a volume of 4.94M, compared to an average daily volume of 3.87M.

The stock's 52-week range extends from a low of $3.81 to a high of $9.60.

The stock's 52-week range extends from a low of $3.81 to a high of $9.60.

VNDA News

Benzinga 2d
What's Going On With Vanda Pharmaceuticals Stock Wednesday?

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading higher Wednesday after the company announced it received FDA approval of NEREUS for the prevention o...

What's Going On With Vanda Pharmaceuticals Stock Wednesday?
Nasdaq 2d
Vanda Pharmaceuticals Stock Surges 29% After FDA Clears Motion Sickness Drug

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) shares jumped 29.13%, trading at $9.08, up $2.05, after the company announced that the U.S. Food and Drug Administ...

Vanda Pharmaceuticals Stock Surges 29% After FDA Clears Motion Sickness Drug
Nasdaq 3d
VNDA Obtains FDA Nod for Motion Sickness Drug, Stock Gains

Vanda Pharmaceuticals, Inc. VNDA announced that the FDA has approved its candidate tradipitant for the prevention of vomiting induced by motion. The drug has b...

VNDA Obtains FDA Nod for Motion Sickness Drug, Stock Gains

More VNDA News

TipRanks 3d
Vanda Wins FDA Approval for NEREUS Motion Sickness Drug

Claim 70% Off TipRanks This Holiday Season Vanda ( (VNDA) ) has issued an announcement. On December 30, 2025, Vanda Pharmaceuticals announced that the U.S. Fo...

Benzinga 3d
Vanda Pharmaceuticals, One Stop Systems And 3 Stocks To Watch Heading Into Wednesday

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Oriental Rise Holdings L...

People also own

Based on the portfolios of people who own VNDA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.